Literature DB >> 23314791

Combined resection of colorectal hepatic-pulmonary metastases shows improved outcome over chemotherapy alone.

Georgios Meimarakis1, Martin Angele, Claudius Conrad, Rolf Schauer, Rolf Weidenhagen, Alexander Crispin, Clemens Giessen, Gerhard Preissler, Max Wiedemann, Karl-Walter Jauch, Volker Heinemann, Sebastian Stintzing, Rudolf A Hatz, Hauke Winter.   

Abstract

BACKGROUND: The objective of this retrospective study was to assess the survival of patients after resection of hepatic and pulmonary colorectal metastases to identify predictors of long-term survival.
METHODS: Patients receiving chemotherapy alone were compared to patients receiving surgery and chemotherapy in a matched-pair analysis with the following criteria: UICC stage, grading, and date of initial primary tumor occurrence.
RESULTS: A total of 30 patients with liver and lung metastases of colorectal carcinoma underwent resection. In 20 cases, complete resection was achieved (median survival, 67 months). Incomplete resection and preoperatively elevated carcinoembryonic antigen (CEA) levels are independent risk factors for reduced survival. Patients developing pulmonary metastases prior to hepatic metastases had the worst prognosis. Surgical resection significantly increased survival compared to chemotherapy alone in matched-pair analysis (65 vs. 30 months, p = 0.03).
CONCLUSIONS: Incomplete resection and elevated CEA levels are predictors of poor outcome. Matched-paired analysis confirmed that surgical resection in combination with chemotherapy appears to be superior to chemotherapy alone.

Entities:  

Mesh:

Year:  2013        PMID: 23314791     DOI: 10.1007/s00423-012-1046-1

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  46 in total

1.  A study of prognostic factors for hepatic resection for colorectal metastases.

Authors:  M Taylor; J Forster; B Langer; B R Taylor; P D Greig; C Mahut
Journal:  Am J Surg       Date:  1997-06       Impact factor: 2.565

2.  Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.

Authors:  Scott Kopetz; George J Chang; Michael J Overman; Cathy Eng; Daniel J Sargent; David W Larson; Axel Grothey; Jean-Nicolas Vauthey; David M Nagorney; Robert R McWilliams
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

3.  Colorectal lung metastases: results of surgical excision.

Authors:  M K McAfee; M S Allen; V F Trastek; D M Ilstrup; C Deschamps; P C Pairolero
Journal:  Ann Thorac Surg       Date:  1992-05       Impact factor: 4.330

4.  Surgical treatment for patients with pulmonary metastases after resection of primary colorectal carcinoma.

Authors:  K Shirouzu; H Isomoto; A Hayashi; Y Nagamatsu; T Kakegawa
Journal:  Cancer       Date:  1995-08-01       Impact factor: 6.860

Review 5.  Surgical therapy of hepatic colorectal metastasis.

Authors:  Y Fong
Journal:  CA Cancer J Clin       Date:  1999 Jul-Aug       Impact factor: 508.702

6.  Simultaneous detection of colorectal carcinoma liver and lung metastases does not warrant resection.

Authors:  S Nagakura; Y Shirai; Y Yamato; N Yokoyama; T Suda; K Hatakeyama
Journal:  J Am Coll Surg       Date:  2001-08       Impact factor: 6.113

7.  Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma.

Authors:  Tommaso Claudio Mineo; Vincenzo Ambrogi; Giuseppe Tonini; Patrizio Bollero; Mario Roselli; Davide Mineo; Italo Nofroni
Journal:  J Am Coll Surg       Date:  2003-09       Impact factor: 6.113

8.  Surgery for lung metastases from colorectal cancer: analysis of prognostic factors.

Authors:  P Girard; M Ducreux; P Baldeyrou; P Rougier; T Le Chevalier; J Bougaran; P Lasser; B Gayet; P Ruffié; D Grunenwald
Journal:  J Clin Oncol       Date:  1996-07       Impact factor: 44.544

9.  Resection of both hepatic and pulmonary metastases in patients with colorectal carcinoma.

Authors:  S Murata; Y Moriya; T Akasu; S Fujita; K Sugihara
Journal:  Cancer       Date:  1998-09-15       Impact factor: 6.860

10.  Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial.

Authors:  Eduardo Díaz-Rubio; Jose Tabernero; Auxiliadora Gómez-España; Bartomeu Massutí; Javier Sastre; Manuel Chaves; Alberto Abad; Alfredo Carrato; Bernardo Queralt; Juan José Reina; Joan Maurel; Encarnación González-Flores; Jorge Aparicio; Fernando Rivera; Ferrán Losa; Enrique Aranda
Journal:  J Clin Oncol       Date:  2007-06-04       Impact factor: 44.544

View more
  4 in total

Review 1.  Resection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomes.

Authors:  William J Hadden; Philip R de Reuver; Kai Brown; Anubhav Mittal; Jaswinder S Samra; Thomas J Hugh
Journal:  HPB (Oxford)       Date:  2016-02-01       Impact factor: 3.647

2.  Pulmonary resection and systemic lymph node dissection in a patient with breast cancer who had a 33-year disease-free interval.

Authors:  Degang Yin; Guofei Zhang; Lufeng Zhao; Ying Chai
Journal:  World J Surg Oncol       Date:  2015-04-16       Impact factor: 2.754

3.  Increased miR-449a expression in colorectal carcinoma tissues is inversely correlated with serum carcinoembryonic antigen.

Authors:  Shaohua Chen; Yuqiao Dai; Xuemei Zhang; Daozhong Jin; Xiaorong Li; Yi Zhang
Journal:  Oncol Lett       Date:  2013-12-06       Impact factor: 2.967

4.  Frameless Single Robotic Radiosurgery for Pulmonary Metastases in Colorectal Cancer Patients.

Authors:  Jobst C Von Einem; Sebastian Stintzing; Dominik P Modest; Michael Wiedemann; Christoph Fürweger; Alexander Muacevic
Journal:  Cureus       Date:  2020-03-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.